Navigation Links
Inovio Pharmaceuticals Closes $4.0 Million Underwritten Financing
Date:12/7/2011

BLUE BELL, Pa., Dec. 7, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), which is advancing synthetic vaccines to fight cancers and infectious diseases, announced today that it has closed an underwritten public offering of 7,699,712 shares of its common stock and warrants to purchase up to 5,774,784 additional shares of its common stock, which included the partial exercise of the underwriter's overallotment option to purchase additional units at the public offering price. The shares and warrants were placed with five institutional investors. These securities were sold in units, consisting of one share of common stock and 0.75 of a warrant to purchase one share of common stock, at a price of $0.5195 per unit. The warrants have a term of five years and an exercise price of $0.65 per share. Inovio may call these warrants if the closing bid price of the common stock has been at least $1.30 over 20 trading daysand certain other conditions are met.

The gross proceeds of the offering were $4.0 million. Net proceeds to Inovio, after deducting the underwriter's discounts and other estimated offering expenses payable by Inovio, were approximately $3.7 million. Brean Murray, Carret & Co. acted as sole bookrunner of this offering. Inovio intends to use the net proceeds from the offering for general corporate purposes, including clinical trial expenses and research and development expenses.

Dr. J. Joseph Kim, President and CEO of Inovio Pharmaceuticals, said "We're pleased to see these institutional investors support our strategy to develop Inovio's synthetic vaccines.  In 2011 we achieved multiple important milestones toward our goal of revolutionizing vaccine technology and we look forward to the clinical outcomes ahead of us in 2012."

The securities described above were offered by Inovio pursuant to a registration statement previously fil
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results
2. Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling
3. Inovio Pharmaceuticals and VGX International to Advance Therapeutic Hepatitis C and Hepatitis B Synthetic Vaccines into Clinical Studies
4. Inovio Pharmaceuticals Leadership for Life Sciences Recognized in the Philadelphia Region
5. Inovio Pharmaceuticals Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
6. Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines Potential to Help Ensure Nations Food Supply Safety
7. Inovio Pharmaceuticals Completes PENNVAX™-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses
8. Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
9. Inovio Pharmaceuticals to Present at Investor Conferences
10. Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results
11. Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... -- Following yesterday,s release of Center for Medicaid and Medicare ... you need to know: ... government programs. , ... parts of Medicare and other government programs because it relies ... prescription drug benefits to enrollees. , Competition and rebates ...
(Date:5/1/2015)... PLEASANTON, Calif. , May 1, 2015  Thoratec Corporation ... support therapies to save, support and restore failing hearts, announced ... the newly created role of President, International. This ... all Thoratec commercial operations outside of North America ... Asia , and Latin America , ...
(Date:5/1/2015)... May 1, 2015  Legendary actor and director ... new PBAFacts campaign designed to educate and encourage patients ... about Pseudobulbar Affect (PBA) and to speak with their ... actor has the ability to cry and laugh on ... control experienced by people living with PBA episodes. ...
Breaking Medicine Technology:5 Things to Know About the CMS Part D Data Release 25 Things to Know About the CMS Part D Data Release 3Thoratec Announces Addition To Senior Management Team 2Thoratec Announces Addition To Senior Management Team 3Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 2Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 3
... Nov. 15, 2010 Spherix Incorporated (Nasdaq: ... diabetes and the metabolic syndrome, and a provider of ... and pharmaceutical companies, today reported results for the three ... and Upcoming Highlights Pharmaceutical Development ...
... 15, 2010 /PRNewswire-- Sangart, Inc., a global ... designed to enhance the perfusion and oxygenation of ... other gas delivery, today announced that its investigational ... designation by the U.S. Food and Drug Administration ...
Cached Medicine Technology:Spherix Announces Third Quarter 2010 Financial Results 2Spherix Announces Third Quarter 2010 Financial Results 3Spherix Announces Third Quarter 2010 Financial Results 4Spherix Announces Third Quarter 2010 Financial Results 5Spherix Announces Third Quarter 2010 Financial Results 6Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease 2Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease 3
(Date:5/2/2015)... 02, 2015 It’s a pattern that ... disaster strikes anywhere on this planet, cyber scammers will ... and compassion for their own personal gain. And ... Readiness Team) issued an alert titled “Nepal Earthquake ... scams citing the earthquake in Nepal. The scam emails ...
(Date:5/2/2015)... 02, 2015 As a nonsurgical ... of the face, neck and décolleté, radiofrequency energy ... real potential for the success of vulvovaginal rejuvenation. ... Clinical Advisory Council, ThermiGyn’s Women’s Health Clinical Advisory ... concluded that ThermiGyn’s temperature controlled radio frequency, specifically ...
(Date:5/1/2015)... Pioneer Millworks, the largest reclaimed wood ... their reclaimed wood products at the 27th annual International ... in NYC this May. Their newest offerings, Vat 35, ... texture and color to North America's platform for global ... and color in the design world and we're excited ...
(Date:5/1/2015)... It’s raining bills on Capitol Hill with members ... federal support for telemedicine. , “Such action is ... with Congress,” said Jonathan Linkous, CEO of the American Telemedicine ... poised to embrace the use of telecommunications in the delivery ... ATA’s mission to improve quality, access, equity and affordability of ...
(Date:5/1/2015)... Today the United Nations Foundation’s Girl Up ... to help protect the rights of adolescent girls in India. ... added since Girl Up began almost five years ago – ... adolescent girls in the Rajasthan region of India. , ... advancement of adolescent girls in Guatemala, Ethiopia, Liberia, and Malawi. ...
Breaking Medicine News(10 mins):Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 2Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 3
... homes, seniors increasingly turning to home care vs. assisted ... estate crisis has affected all aspects of life, and ... unable to sell their homes, moving to an assisted ... reason, the option of aging-in-place with retrofits is growing ...
... lead to blood clots, study says , , THURSDAY, Jan. ... don,t seem to increase the risk of heart disease as ... , But more research on the newer generations of contraceptives ... true because more women over age 35 are taking hormonal ...
... spending on health IT, Congress should first fix the ... control over their personal health information," says Sue A. ... "Right now, the HIPAA privacy rule has too ... Blevins stresses. , , IHF released ...
... cancer patient Debra Gardocki receives an injection from oncologist ... a new approach to treat advanced melanoma -- an ... limited effective treatment options. The study -- which is ... United States and Canada -- includes combining a therapeutic ...
... The $800 million settlement that Eli,Lilly and Company (NYSE: ... civil False Claims,Act charges related to allegedly false or fraudulent ... to the courageous stands taken by,employee whistleblowers, according to the ... The company,s settlement with the federal government, which also includes,a ...
... Awards ScholarshipWASHINGTON, Jan. 15 High ... chance to score some extra cash from got milk?(R) for ... with USA TODAY, has launched the 12th annual Scholar Athlete ... Awards reward 25 high school senior student athletes who demonstrate ...
Cached Medicine News:Health News:Housing Crisis Affects Seniors Needing Care 2Health News:Housing Crisis Affects Seniors Needing Care 3Health News:Newer Contraceptives Don't Increase Heart Risk 2Health News:Newer Contraceptives Don't Increase Heart Risk 3Health News:Economic Stimulus Package Could Impinge on Americans' Health Privacy 2Health News:A Shot in the Arm to Fight Skin Cancer 2Health News:Whistleblowers' Complaints Lead Eli Lilly to Pay $800 Million to Settle Civil Medicaid Fraud Charges, According to Berg & Androphy 2Health News:Video: Teen Athletes Who Stay Fit With Milk Can Earn Cash for College 2Health News:Video: Teen Athletes Who Stay Fit With Milk Can Earn Cash for College 3
Combined Screen (RNP, Sm, Jo-1, Scl-70, SS-A, SS-B) ELISA kit....
... Scientific, Inc. ENA Screen ELISA test system ... detect antibodies to extractable nuclear antigens (anti-ENA) ... the directional insert, this test system is ... for, such as those against Jo-1, Sm, ...
... Single Well Screening Kit is designed to screen ... autoantibodies. Each microtiter well is coated with Sm, ... allows the laboratory to cost effectively screen out ... the ENA specificity on any of the company's ...
The K-ASSAY Rheumatoid Factor Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifying...
Medicine Products: